Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of $182.11 billion. The enterprise value is $194.12 billion.
| Market Cap | 182.11B |
| Enterprise Value | 194.12B |
Important Dates
The next estimated earnings date is Tuesday, April 30, 2024, before market open.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | Mar 7, 2024 |
Share Statistics
Novartis AG has 1.96 billion shares outstanding.
| Shares Outstanding | 1.96B |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 6.92% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 22.73 and the forward PE ratio is 13.25. Novartis AG's PEG ratio is 5.09.
| PE Ratio | 22.73 |
| Forward PE | 13.25 |
| PS Ratio | 3.90 |
| Forward PS | 3.69 |
| PB Ratio | 3.90 |
| P/FCF Ratio | 13.36 |
| PEG Ratio | 5.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.29, with an EV/FCF ratio of 14.24.
| EV / Earnings | 13.07 |
| EV / Sales | 4.16 |
| EV / EBITDA | 7.29 |
| EV / EBIT | 11.94 |
| EV / FCF | 14.24 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.57.
| Current Ratio | 1.16 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 0.99 |
| Debt / FCF | 1.94 |
| Interest Coverage | 19.01 |
Financial Efficiency
Return on equity (ROE) is 31.50% and return on invested capital (ROIC) is 12.88%.
| Return on Equity (ROE) | 31.50% |
| Return on Assets (ROA) | 13.60% |
| Return on Capital (ROIC) | 12.88% |
| Revenue Per Employee | $613,487 |
| Profits Per Employee | $195,248 |
| Employee Count | 76,057 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.91 |
Taxes
In the past 12 months, Novartis AG has paid $551.00 million in taxes.
| Income Tax | 551.00M |
| Effective Tax Rate | 3.58% |
Stock Price Statistics
The stock price has decreased by -4.99% in the last 52 weeks. The beta is 0.48, so Novartis AG's price volatility has been lower than the market average.
| Beta (1Y) | 0.48 |
| 52-Week Price Change | -4.99% |
| 50-Day Moving Average | 98.61 |
| 200-Day Moving Average | 99.81 |
| Relative Strength Index (RSI) | 34.81 |
| Average Volume (30 Days) | 1,498,650 |
Short Selling Information
| Short Interest | 4.21M |
| Short Previous Month | 4.53M |
| Short % of Shares Out | 0.26% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.77 |
Income Statement
In the last 12 months, Novartis AG had revenue of $46.66 billion and earned $14.85 billion in profits. Earnings per share was $7.10.
| Revenue | 46.66B |
| Gross Profit | 34.19B |
| Operating Income | 9.77B |
| Pretax Income | 15.40B |
| Net Income | 14.85B |
| EBITDA | 26.63B |
| EBIT | 16.26B |
| Earnings Per Share (EPS) | $7.10 |
Balance Sheet
The company has $14.43 billion in cash and $26.44 billion in debt, giving a net cash position of -$12.01 billion or -$6.14 per share.
| Cash & Cash Equivalents | 14.43B |
| Total Debt | 26.44B |
| Net Cash | -12.01B |
| Net Cash Per Share | -$6.14 |
| Equity / Book Value | 46.67B |
| Book Value Per Share | 23.85 |
| Working Capital | 4.09B |
Cash Flow
In the last 12 months, operating cash flow was $14.46 billion and capital expenditures -$823.00 million, giving a free cash flow of $13.64 billion.
| Operating Cash Flow | 14.46B |
| Capital Expenditures | -823.00M |
| Free Cash Flow | 13.64B |
| FCF Per Share | $6.65 |
Margins
Gross margin is 73.27%, with operating and profit margins of 20.94% and 31.83%.
| Gross Margin | 73.27% |
| Operating Margin | 20.94% |
| Pretax Margin | 33.01% |
| Profit Margin | 31.83% |
| EBITDA Margin | 57.06% |
| EBIT Margin | 34.84% |
| FCF Margin | 29.22% |
Dividends & Yields
This stock pays an annual dividend of $3.78, which amounts to a dividend yield of 4.06%.
| Dividend Per Share | $3.78 |
| Dividend Yield | 4.06% |
| Dividend Growth (YoY) | 8.88% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 53.20% |
| Buyback Yield | 3.95% |
| Shareholder Yield | 8.01% |
| Earnings Yield | 8.15% |
| FCF Yield | 7.49% |
Analyst Forecast
The average price target for Novartis AG is $114.00, which is 22.48% higher than the current price. The consensus rating is "Hold".
| Price Target | $114.00 |
| Price Target Difference | 22.48% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 2.04% |
| EPS Growth Forecast (5Y) | 2.34% |
Stock Splits
The last stock split was on April 9, 2019. It was a forward split with a ratio of 1116:1000.
| Last Split Date | Apr 9, 2019 |
| Split Type | Forward |
| Split Ratio | 1116:1000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |